188 related articles for article (PubMed ID: 33555110)
21. Agreement between the Cochrane risk of bias tool and Physiotherapy Evidence Database (PEDro) scale: A meta-epidemiological study of randomized controlled trials of physical therapy interventions.
Moseley AM; Rahman P; Wells GA; Zadro JR; Sherrington C; Toupin-April K; Brosseau L
PLoS One; 2019; 14(9):e0222770. PubMed ID: 31536575
[TBL] [Abstract][Full Text] [Related]
22. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.
Vale CL; Tierney JF; Burdett S
BMJ; 2013 Apr; 346():f1798. PubMed ID: 23610376
[TBL] [Abstract][Full Text] [Related]
23. Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models.
Lai H; Ge L; Sun M; Pan B; Huang J; Hou L; Yang Q; Liu J; Liu J; Ye Z; Xia D; Zhao W; Wang X; Liu M; Talukdar JR; Tian J; Yang K; Estill J
JAMA Netw Open; 2024 May; 7(5):e2412687. PubMed ID: 38776081
[TBL] [Abstract][Full Text] [Related]
24. RobotReviewer: evaluation of a system for automatically assessing bias in clinical trials.
Marshall IJ; Kuiper J; Wallace BC
J Am Med Inform Assoc; 2016 Jan; 23(1):193-201. PubMed ID: 26104742
[TBL] [Abstract][Full Text] [Related]
25. Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews.
Kabir A; Sofi-Mahmudi A; Karimi Behnagh A; Eidkhani V; Baradaran HR; Kabiri P; Haghdoost A; Mesgarpour B
Arch Iran Med; 2022 Jun; 25(6):375-382. PubMed ID: 35943017
[TBL] [Abstract][Full Text] [Related]
26. Quality of the Systematic Reviews in Cochrane Gynecological Cancer Group and Their Understudied RCTs.
Hajebrahimi S; Dalir Akbari N; Haji Kamanaj A; Hassannezhad S; Aminizadeh S; Darvishi F; HajEbrahimi R; Salehi-Pourmehr H
J Obstet Gynaecol India; 2022 Aug; 72(Suppl 1):346-351. PubMed ID: 35928093
[TBL] [Abstract][Full Text] [Related]
27. Assessment of risk of bias in quasi-randomized controlled trials and randomized controlled trials reported in the
Kim JH; Kim TK; In J; Lee DK; Lee S; Kang H
Korean J Anesthesiol; 2017 Oct; 70(5):511-519. PubMed ID: 29046770
[TBL] [Abstract][Full Text] [Related]
28. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
29. Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests.
Ferrante di Ruffano L; Dinnes J; Sitch AJ; Hyde C; Deeks JJ
BMC Med Res Methodol; 2017 Feb; 17(1):35. PubMed ID: 28236806
[TBL] [Abstract][Full Text] [Related]
30. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study.
Hartling L; Ospina M; Liang Y; Dryden DM; Hooton N; Krebs Seida J; Klassen TP
BMJ; 2009 Oct; 339():b4012. PubMed ID: 19841007
[TBL] [Abstract][Full Text] [Related]
31. Quantifying bias in randomized controlled trials in child health: a meta-epidemiological study.
Hartling L; Hamm MP; Fernandes RM; Dryden DM; Vandermeer B
PLoS One; 2014; 9(2):e88008. PubMed ID: 24505351
[TBL] [Abstract][Full Text] [Related]
32. In Cochrane reviews, risk of bias assessments for allocation concealment were frequently not in line with Cochrane's Handbook guidance.
Propadalo I; Tranfic M; Vuka I; Barcot O; Pericic TP; Puljak L
J Clin Epidemiol; 2019 Feb; 106():10-17. PubMed ID: 30312657
[TBL] [Abstract][Full Text] [Related]
33. Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study.
da Costa BR; Beckett B; Diaz A; Resta NM; Johnston BC; Egger M; Jüni P; Armijo-Olivo S
Syst Rev; 2017 Mar; 6(1):44. PubMed ID: 28253938
[TBL] [Abstract][Full Text] [Related]
34. Risk of bias and magnitude of effect in orthodontic randomized controlled trials: a meta-epidemiological review.
Koletsi D; Spineli LM; Lempesi E; Pandis N
Eur J Orthod; 2016 Jun; 38(3):308-12. PubMed ID: 26174770
[TBL] [Abstract][Full Text] [Related]
35. Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.
Barcot O; Boric M; Dosenovic S; Puljak L
BMC Med Res Methodol; 2021 Jul; 21(1):149. PubMed ID: 34275437
[TBL] [Abstract][Full Text] [Related]
36. Lamotrigine add-on for drug-resistant partial epilepsy.
Ramaratnam S; Panebianco M; Marson AG
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
[TBL] [Abstract][Full Text] [Related]
37. Do acupuncture trials have lower risk of bias over the last five decades? A methodological study of 4 715 randomized controlled trials.
Long Y; Chen R; Guo Q; Luo S; Huang J; Du L
PLoS One; 2020; 15(6):e0234491. PubMed ID: 32520964
[TBL] [Abstract][Full Text] [Related]
38. Randomised clinical trials on acupuncture in the Korean literature: bibliometric analysis and methodological quality.
Kim S; Sagong HS; Kong JC; Choi JY; Lee MS; Wieland LS; Manheimer E; Shin BC
Acupunct Med; 2014 Apr; 32(2):160-6. PubMed ID: 24280950
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
